A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients
NCT04432766
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
strategic decision
Conditions
COVID-19
Interventions
DRUG:
BAT2020
Sponsor
Bio-Thera Solutions